Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al

被引：3
|
作者：
Berkhout, Lea C. [1 ]
l'Ami, Merel J. [2 ]
Wolbink, Gerrit Jan [1 ,2 ]
Rispens, Theo [1 ]
机构：
[1] Sanquin Res, Immunopathol, Amsterdam, Netherlands
[2] Amsterdam Rheumatol & Immunol Ctr, Reade, Amsterdam, Netherlands
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2021年 / 80卷 / 11期
关键词：
anti-TNF; disease activity; rheumatoid arthritis; TNF-alpha; treatment;
D O I：
10.1136/annrheumdis-2019-216557
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页数：1
相关论文
共 42 条
  • [1] Response to: 'Comment on 'Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial' by Tanaka et al' by Berkhout et al
    Tanaka, Yoshiya
    Oba, Koji
    Takeuchi, Tsutomu
    ANNALS OF THE RHEUMATIC DISEASES, 2021, 80 (11)
  • [2] Sustained discontinuation of infliximab with a raising-dose strategy after obtaining remission in patients with rheumatoid arthritis: the RRRR study, a randomised controlled trial
    Tanaka, Yoshiya
    Oba, Koji
    Koike, Takao
    Miyasaka, Nobuyuki
    Mimori, Tsuneyo
    Takeuchi, Tsutomu
    Hirata, Shintaro
    Tanaka, Eiichi
    Yasuoka, Hidekata
    Kaneko, Yuko
    Murakami, Kosaku
    Koga, Tomohiro
    Nakano, Kazuhisa
    Amano, Koichi
    Ushio, Kazuyasu
    Atsumi, Tatsuya
    Inoo, Masayuki
    Hatta, Kazuhiro
    Mizuki, Shinichi
    Nagaoka, Shouhei
    Tsunoda, Shinichiro
    Dobashi, Hiroaki
    Horie, Nao
    Sato, Norihiro
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 (01) : 94 - 102
  • [3] Sustained Clinical Remission after Discontinuation of Infliximab with a Raising Dose Strategy in Patients with Rheumatoid Arthritis (RRRR study): A Randomized Controlled Trial
    Tanaka, Yoshiya
    Oba, Koji
    Koike, Takao
    Miyasaka, Nobuyuki
    Mimori, Tsuneyo
    Takeuchi, Tsutomu
    Hirata, Shintaro
    Tanaka, Eiichi
    Yasuoka, Hidekata
    Kaneko, Yuko
    Murakami, Kosaku
    Koga, Tomohiro
    Nakano, Kazuhisa
    Amano, Koichi
    Ushio, Kazuyasu
    Atsumi, Tatsuya
    Inoo, Masayuki
    Hatta, Kazuhiro
    Mizuki, Shinichi
    Nagaoka, Shohei
    Tsunoda, Shinichiro
    Dobashi, Hiroaki
    Horie, Nao
    Sato, Norihiro
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [4] Sustained remission following the discontinuation of tofacitinib in patients with rheumatoid arthritis (XANADU study): an open-label randomised study
    Kubo, Satoshi
    Miyazaki, Yusuke
    Amano, Koichi
    Matsui, Kiyoshi
    Kameda, Hideto
    Inoue, Yoshino
    Nakayamada, Shingo
    Ogura, Takehisa
    Kaneko, Yuko
    Yamaoka, Kunihiro
    Tanaka, Yoshiya
    RMD OPEN, 2023, 9 (02):
  • [5] Sustained Remission Following the Discontinuation of Tofacitinib in Patients with Rheumatoid Arthritis (XANADU Study): A Multicenter, Prospective, and Randomized Controlled Study
    Kubo, Satoshi
    Miyazaki, Yusuke
    Amano, Koichi
    Matsui, Kiyoshi
    Kameda, Hideto
    Inoue, Yoshino
    Nakayamada, Shingo
    Ogura, Takehisa
    Kaneko, Yuko
    Yamaoka, Kunihiro
    Tanaka, Yoshiya
    ARTHRITIS & RHEUMATOLOGY, 2022, 74 : 3136 - 3139
  • [6] Sustained effect after lowering high-dose infliximab in patients with rheumatoid arthritis: a prospective dose titration study
    van den Bemt, B. J. F.
    den Broeder, A. A.
    Snijders, G. F.
    Hekster, Y. A.
    van Riel, P. L. C. M.
    Benraad, B.
    Wolbink, G. J.
    van den Hoogen, F. H. J.
    ANNALS OF THE RHEUMATIC DISEASES, 2008, 67 (12) : 1697 - 1701
  • [7] DISCONTINUATION OF ETANERCEPT IN EARLY RHEUMATOID ARTHRITIS PATIENTS WHO HAVE ACHIEVED SUSTAINED REMISSION: RESULTS OF THE RANDOMIZED CONTROLLED TRIAL IN PERIOD 2 OF THE ENCOURAGE STUDY
    Yamanaka, H.
    Seto, Y.
    Nagaoka, S.
    Bae, S. -C.
    Kasama, T.
    Lee, S. -K.
    Kobayashi, H.
    Nishioka, Y.
    Tanaka, Y.
    Takeuchi, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2014, 73 : 239 - 239
  • [8] Discontinuation of infliximab after attaining low disease activity in patients with rheumatoid arthritis: RRR (remission induction by Remicade in RA) study
    Tanaka, Y.
    Takeuchi, T.
    Mimori, T.
    Saito, K.
    Nawata, M.
    Kameda, H.
    Nojima, T.
    Miyasaka, N.
    Koike, T.
    ANNALS OF THE RHEUMATIC DISEASES, 2010, 69 (07) : 1286 - 1291
  • [9] Discontinuation of infliximab therapy in patients with Crohn's disease in sustained complete remission (the STOP IT study): protocol for a double-blind, randomised, placebo-controlled, multicentre trial
    Buhl, Sine Schnoor
    Steenholdt, Casper
    Brynskov, Jorn
    Thomsen, Ole Ostergaard
    Bendtzen, Klaus
    Ainsworth, Mark Andrew
    BMJ OPEN, 2014, 4 (12):
  • [10] Does intensive management improve remission rates in patients with intermediate rheumatoid arthritis? (the TITRATE trial): study protocol for a randomised controlled trial
    Naomi H. Martin
    Fowzia Ibrahim
    Brian Tom
    James Galloway
    Allan Wailoo
    Jonathan Tosh
    Heidi Lempp
    Louise Prothero
    Sofia Georgopoulou
    Jackie Sturt
    David L. Scott
    Trials, 18
12345